StockSelector.com
  Research, Select, & Monitor Saturday, May 30, 2015 12:12:10 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
   Diversify with StockSelector.com
- the tools for short-term traders and long-term investors to find successful ideas to fit their strategies and to keep informed of the stocks you follow or hold. Take a macro look at the market and by industry, narrow down to specific stocks and the right time, then use our portfolio to monitor the stocks and be alerted of changes.


 Sector ETF's Price Change  
Consumer Discret Select Sector SPDR 76.30 (0.69%)
Consumer Staples Select Sector SPDR 48.79 (0.63%)
Energy Select Sector SPDR 78.39 (0.11%)
Financial Select Sector SPDR 24.60 (0.89%)
Healthcare Select Sector SPDR 74.94 (0.25%)
Industrial Select Sector SPDR 55.81 (0.99%)
Materials Select Sector SPDR 50.61 (0.65%)
Technology Select Sector SPDR 43.37 (0.73%)
Utilities Select Sector SPDR 44.50 (0.16%)

 Most Oversold Industry
 Auto Manufacturers - Major
These firms are some of the largest vehicle manufacturers in the world. They produce the obvious cars, trucks, buses, vans, and motorcycles. Recreational vehicles, mini-vans, luxury cars, components, and construction equipment are some of their other related items on the production lines. Many firms also offer financing of their goods and in a field tied to vehicle financing, one firm here offers mortgages and even auto and homeowner's insurance. They typically sell their product to the consumer through auto dealerships located domestically and abroad.


HP Reports In-line
5/21/2015 4:05:34 PM


0.74%
Hewlett-Packard Co. (HPQ) reported second quarter earnings of $0.87 per share on revenue of $25.45 billion. The consensus earnings estimate was $0.86 per share on revenue of $25.69 billion for the quarter ending April 30, 2015. The ... more

Take-Two Beats
5/18/2015 4:05:02 PM


1.05%
Take-Two Interactive Software, Inc. (TTWO) reported fourth quarter non-GAAP earnings of $0.49 per share with non-GAAP revenue of $427.7 million. The consensus earnings estimate was $0.27 per share on revenue of $458.9 million for the ... more

Tesla Beats, Guides Lower
5/6/2015 4:42:30 PM


0.26%
Tesla Motors, Inc. (TSLA) reported a first quarter non-GAAP loss of $0.36 per share on revenue of $1.10 billion. The consensus estimate was a loss of $0.50 per share on revenue of $1.0 billion for the quarter ending March 31, 2015. ... more

GoPro Beats by a Penny
4/28/2015 4:05:00 PM


2.38%
GoPro, Inc. (GPRO) reported first quarter non-GAAP earnings of $0.24 per share on revenue of $363.1 million. The consensus earnings estimate was $0.18 per share on revenue of $341.7 million for the quarter ending March 31, 2015. The ... more

Twitter Reports Earnings In-line; Revenue Misses
4/28/2015 3:31:00 PM


0.43%
Twitter, Inc. (TWTR) reported first quarter non-GAAP earnings of $0.07 per share on revenue of $436.0 million. The consensus earnings estimate was $0.04 per share on revenue of $456.5 million for the quarter ending March 31, 2015. ... more

Apple Modestly Beats Earnings
4/27/2015 4:30:01 PM


1.14%
Apple, Inc. (AAPL) reported second quarter earnings of $2.33 per share on revenue of $58.01 billion. The consensus earnings estimate was $2.19 per share on revenue of $55.19 billion for the quarter ending March 31, 2015. The Earnings ... more

 StockSelector's Top Ranked Stock
 DepoMed, Inc.
Positive Points:20
Negative Points:4
Depomed, Inc. is a specialty pharmaceutical company utilizing its innovative AcuForm drug delivery technology to develop novel oral products and improved, extended release formulations of existing oral drugs. AcuForm-based products are designed to provide once- daily administration and reduced side effects, improving patient convenience, compliance and pharmacokinetic profiles. ProQuin XR extended-release tablets have been approved by the FDA for the once-daily treatment of uncomplicated urinary tract infections and are currently being marketed in the United States. In addition, once-daily Glumetza has been approved for use in adults with type two diabetes and is currently being marketed in the United States and Canada. The company is currently evaluating Gabapentin GR for the treatment of two pain indications, postherpetic neuralgia and diabetic peripheral neuropathy, and menopausal hot flashes.

 Potential Breakout Stock
 Fluidigm Corporation
Fluidigm Corporation operates as a biotech tools company that creates microfluidic-based chips and instrumentation for biological research. Products offered by the Company include BioMark HD System- a real time PCR; EP1 system for SNP genotyping; Access Array System-an Integrated Fluidic Circuit (IFC); TOPAZ system for protein crystallography; Dynamic Array integrated fluidic circuits (IFCs); and Access Array Assay Design Services. The Company's products find its application in Gene Expression, Single-Cell Gene Expression, SNP Genotyping, Targeted Resequencing, Sample Quantitation, Copy Number Variation and Protein Crystallization. Fluidigm Corporation is based in San Francisco, California.











Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Quotes are delayed by 15-20 minutes. Quotes provided by QuoteMedia

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2015 StockSelector.com. All rights reserved.